Sodium or potassium outside normal reference range for site
Serum potassium within normal range.
Serum potassium within normal range.
Potassium (K) should be within the range of >= 3.6 mEq/L
Potassium within normal range (supplementation is allowed)
Within 28 days prior to treatment start: Potassium within institutional normal range
Patients with uncorrectable electrolyte abnormalities with potassium (K) > ULN (upper limit of normal)
Serum sodium and potassium within the institutional limits of normal, within 14 days of registration and within 7 days of the start of treatment
Potassium within normal limits (WNL)
Potassium within institutional normal limits
Potassium within institutional normal limit (WNL)
Potassium within normal limits prior to the first dose of study medication
Potassium within normal limits for the institution
Potassium > 3 and < 5.5 mEq/L
Potassium between range of 3.0 to 5.5
Potassium in normal range\r\n* Patients with hypokalemia at screening must be corrected prior to initiating treatment
Serum potassium >= 3.5 mEq/L
Patients with sodium, potassium, or creatinine serum electrolytes > grade 2.
Potassium within normal limits for the institution
Potassium 3.5-5.0 mEq/L
Potassium within normal limits (oral supplementation is allowed)
Baseline serum potassium < 3.5 mmol/L (potassium supplementation may be given to restore the serum potassium above this level prior to study entry)
Serum potassium within normal limits
Subjects must have potassium (K+) >3.5 mEq/l.
Serum potassium >= 3.5 mEq/L\r\n* Hypokalemia can be managed and corrected at the physician’s discretion; patients who have hypokalemia must have a repeat serum potassium level drawn within 7 days before starting study drug; patients with a supported potassium level at >= 3.5 can be considered eligible at the physician’s discretion
Serum potassium levels outside the laboratory’s reference range
Serum potassium within institutional limits of normal (may be corrected with potassium repletion)
Potassium within normal limits for the institution
Serum or plasma potassium >= 3.5 mmol/L or institutional lower limit of normal (LLN) (independent of potassium supplementation)
Serum potassium >= 3.5 mEq/L
Potassium within normal limits for the institution
Obtained =< 7 days prior to registration: Potassium WNL
Potassium within normal limits
Serum potassium >= 3.5 mEq/L
Potassium
Potassium =< 3.5 mEq/L
Potassium levels =< grade 1
Use of potassium wasting diuretics during study treatment
Serum potassium within normal limits (WNL)
Potassium (K) levels: preferred normal limits with no clinical abnormalities
Potassium levels within normal limits
Potassium within normal limits for the institution
Potassium >= 3.0 mg/dl and =< upper limit of normal
Serum potassium > 3.3; electrolyte repletion is allowed to reach these values
Adequate potassium level > 3.5 mEq/dL
Because of the potential risk of corrected QT (QTc) changes, serum potassium levels must be within institutional normal limits
Potassium within normal limits for the institution
Serum potassium of >= 3.5 mEq/L
Serum potassium must be within institutional normal limits
Potassium within the normal range of 3.5-5.3 mEq/L
Potassium with institutional limits (supplementation allowed)
Potassium >= 3.5 mg/dL
Potassium within institutional range, obtained within 14 days prior to treatment start
Potassium within normal limits
Sodium, potassium, chloride, bicarbonate: all =< upper limit of institutional normal
Potassium (K) within 2 x ULN
Hypersensitivity to potassium iodide or Lugols products
